Share This Article:

Crystal Structure and Synthesis of 3β-(p-Iodobenzoyloxy)-16α,17α-Epoxypregn-4-En-6,20-Dione

Abstract Full-Text HTML XML Download Download as PDF (Size:533KB) PP. 39-47
DOI: 10.4236/csta.2014.32005    4,438 Downloads   5,192 Views  

ABSTRACT

3β-(p-iodobenzoyloxy)-16α,17α-epoxypregn-4-en-6,20-dione (7), C28H31O5I, was synthesized from the commercially available 16-dehydropregnenolone acetate. X-ray diffraction analysis of (1) demonstrated that it consisted of four rings, three six-membered rings (A, B and C) and one five-membered ring (D). A, B, C and D rings occur in an envelope, deformed chair, deformed chair, and the half chair conformations, respectively. The absolute configurations of 7 for the chiral centers are 3S, 8S, 9S, 10R, 13S and 14S. The crystal of 3β-(p-iodobenzoyloxy)-16α,17α-epoxypregn-4-en-6,20-dione is in monoclinic crystal system with space group P21, lattice constants: a = 10.8567 (11), b = 7.5479 (7), c = 16.0391 (16) Å, β = 109.473 (1)°, V = 1239.1 (2) Å3, Dx = 1.518 g/cm3 and Z = 2. The molecules in the crystal are stabilized by C-H···O interactions and van der Waals forces.

Conflicts of Interest

The authors declare no conflicts of interest.

Cite this paper

Chávez-Riveros, A. , Cabeza, M. , Bratoeff, E. and Soriano-García, M. (2014) Crystal Structure and Synthesis of 3β-(p-Iodobenzoyloxy)-16α,17α-Epoxypregn-4-En-6,20-Dione. Crystal Structure Theory and Applications, 3, 39-47. doi: 10.4236/csta.2014.32005.

References

[1] Stankov, A., Bargallo-Rocha, J.E., Namendis-Silva, S., Ramirez, M.T., Stankova-Ninova, K. and Meneses-Garcia, A. (2012) Prognostic Factors and Recurrence in Breast Cancer: Experience at National Cancer Institute of Mexico. ISRN Oncology, 2012, 1-7.
http://dx.doi.org/10.5402/2012/825258
[2] Sutcliffe, S. and Colditz, G. (2013) Prostate Cancer: Is It Time to Expand the Research Focus to Early-Life Exposures? Nature Reviews Cancer, 3, 208-218.
http://dx.doi.org/10.1038/nrc3434
[3] Siegel, R., Naishadham, D. and Jemal, A. (2013) Cancer Statistics, 2013. Cancer Journal for Clinicians, 63, 11-30.
http://dx.doi.org/10.3322/caac.21166
[4] Machetti, F. and Guarna, A. (2002) Novel Inhibitors of 5α-Reductase. Expert Opinion on Therapeuty Patents, 12, 201-215.
http://dx.doi.org/10.1517/13543776.12.2.201
[5] Rick, F.G., Saadat, S.H., Szalontay, L., Block, N.L., Kazzazi, A., Djavan, B. and Schally, A.V. (2013) Hormonal Manipulation of Benign Prostatic Hyperplasia. Current Opinion in Urology, 23, 17-24.
http://dx.doi.org/10.1097/MOU.0b013e32835abd18
[6] Flores, E., Bratoeff, E., Cabeza, M., Ramirez, E., Quiroz, A. and Heuze, I. (2003) Steroid 5α-Reductase Inhibitors. Mini Reviews in Medicinal Chemistry, 3, 225-237.
http://dx.doi.org/10.2174/1389557033488196
[7] Bratoeff, E., Garcia, P., Heuzeb, Y., Soriano, J., Mejia, A., Labastida, A.M., Valencia, N. and Cabeza, M. (2010) Molecular Interaction of Progesterone Derivatives with 5α-Reductase Type 1 and 2 and Androgen Receptors. Steroids, 75, 499-505.
http://dx.doi.org/10.1016/j.steroids.2010.03.006
[8] Bratoeff, E., Zambrano, A., Heuze, I., Palacios, A., Ramirez, D. and Cabeza, M. (2010) Synthesis and Biological Activity of Progesterone Derivatives as 5α-Reductase Inhibitors, and Their Effect on Hamster Prostate Weight. Journal of Enzyme Inhibition and Medicinal Chemistry, 25, 306-311.
http://dx.doi.org/10.3109/14756360903179401
[9] Martinez, R., Avila, J.G., Ramirez, M.T., Perez, A. and Martinez, A. (2006) Tetrahydropyrrol[3,2-c]Azepin-4-Ones as a New Class of Cytotoxic Compounds. Bioorganic & Medicinal Chemistry, 14, 4007-4016.
http://dx.doi.org/10.1016/j.bmc.2006.02.012
[10] Bruker (2009) APEX2, SAINT and SADABS. Bruker AXS Inc., Madison.
[11] Sheldrick, G.M. (2008) A Short History of SHELX. Acta Crystallographica, A64, 112-122.
http://dx.doi.org/10.1107/S0108767307043930
[12] Flack, H.D. (1983) On Enantiomorph-Polarity Estimation. Acta Crystallographica, A39, 876-881.
http://dx.doi.org/10.1107/S0108767383001762
[13] Goubitz, K., Schenk, H. and Zeelen, F.J. (1984) Conformational-Analysis of 20-Keto Steroids—Single-Crystal X-Ray Structure-Analysis of 16-Alpha, 17-Epoxy-4-Pregnene-3,20-Dione. Steroids, 44, 153-158.
http://dx.doi.org/10.1016/S0039-128X(84)90081-3
[14] Duax, W.L., Griffin, J.F., Strong, P.D., Funder, J.W. and Ulick, S. (1982) Molecular-Structure of 18-Deoxyaldosterone and Its Relationship to Receptor-Binding and Activity. Journal of the American Chemical Society, 104, 7291-7293.
http://dx.doi.org/10.1021/ja00389a063
[15] Bernes, S., Torrens, H., Lopez-Giral, A. and Buttenklepper, A. (2003) Pregnenolone Hemisuccinate: A P1 Structure with Z’ = 4. Acta Crystallographica, E59, o1372-o1375.
http://dx.doi.org/10.1107/S160053680301835X
[16] Soriano-Garcia, M., Zambrano, A., Cabeza, M. and Bratoeff, E. (2009) Crystal Structure and Synthesis of 17α-Acetoxy-6,7-Epoxypregn-4-Ene-3,20-Dione. The Japan Society for Analytical Chemistry, 25, 61-62.
[17] Cremer, D. and Pople, J.A. (1975) General Definition of Ring Puckering Coordinates. Journal of the American Chemical Society, 97, 1354-1358.
http://dx.doi.org/10.1021/ja00839a011
[18] Desiraju, G.R., Kashino, S., Cooms, M.M. and Glusker, J.P. (1993) C-HO Packing Motifs in Some Cyclopenta[a]Phenanthrenes. Acta Crystallographica, B49, 880-892.
http://dx.doi.org/10.1107/S0108768193001703

  
comments powered by Disqus

Copyright © 2019 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.